“…In AD, ML methods were applied for defining DTI metrics ( Konukoglu et al, 2016 ; Lombardi et al, 2020 ; Xu et al, 2021 ; Agostinho et al, 2022 ) to characterize MCI ( Velazquez and Lee, 2022 ; Zhou et al, 2022a , b ; Cheng et al, 2023 ) and to predict AD early ( Savarraj et al, 2022 ). The characterization of MCI and cognitive impairment in PD ( Xu et al, 2021 ; Yang Y. et al, 2022 ; Chen B. et al, 2023 ; Huang et al, 2023 ) or the investigation of progression in PD ( Prasuhn et al, 2020 ; Yang et al, 2021a , b ) has also been addressed by the application of ML methods. Furthermore, ML was applied to the differentiation of parkinsonian syndromes ( Haller et al, 2012 ; Du et al, 2017 ; Chougar et al, 2021 ; Talai et al, 2021 ).…”